Est. 2001·3,000+ placements · six offices · four regions

Company signals

10x Genomics

2 signals in the current window, with MitchelLake's leadership read on each.

Market context: The wider read — a Talent Market Index of 110 (Hot), up 11.7 month-on-month — shows Americas signal flow easing (-12.5pts).

10x Genomics: 2 signals in the last 90 days; 0.1% of MitchelLake's Americas signal flow; 2 tracked across 61 days.

Signals at 10x Genomics

More signals across Americas

Product Launch · Americas

SABIC

SABIC launched NORYL V0150TW and V0150IR2 laser-weldable thermoplastic resins designed for solar microinverters, tracker boxes, and junction boxes. The resins enable shift from ultrasonic welding/adhesive bonding to laser welding, reducing production cycle times and assembly costs by up to 30% material usage reduction and 40% part size reduction.

Product Launch · Americas

Zensar Technologies

Zensar Technologies launched ZenseAI.AgentMesh, an enterprise-grade agentic AI platform designed to help organizations discover, build, and deploy AI solutions at scale.

Product Launch · Americas

Danone

Danone expanded its Silk Protein line with dairy-free yoghurts (13g protein per 6oz serving) and ready-to-drink protein shakes (30g protein per 11.15oz bottle). Yoghurts launching nationwide later this month; shakes rolling out next month across the US.

Product Launch · Americas

Netskope

Netskope released its 2026 Cloud and Threat Report, revealing that nearly 50% of enterprise generative AI users access unsanctioned AI tools through personal accounts, with an average organization reporting 223 AI policy violations monthly. The report identifies shadow AI as adding $670,000 to average breach costs.

Product Launch · Americas

Medtronic

Medtronic received FDA 510(k) clearance in June 2026 for its Nellcor pulse oximetry system with Nell-EQ intelligent processor. Product designed to improve oxygen saturation and pulse rate monitoring accuracy across diverse skin tones and care settings, aligned with new ISO 80601-2-61:2026 standards.

Product Launch · Americas

Neurocrine Biosciences

Neurocrine presented CRENESSITY clinical data at ENDO 2026 demonstrating hormone normalization in classic CAH and two-year cardiometabolic and bone health outcomes in adults.

Weekly briefing

Track companies like 10x Genomics — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗

Nearby in the record

Share: WhatsApp · X · Email